Destroying c-jun Messenger: new insights into biological mechanisms of DNAzyme function
Abstract:
The study by Cai and co-workers provided novel insights into the mechanism of action of DNAzymes. Dz13 rendered c-jun mRNA unstable, reduced growth factor expression and increased apoptosis in the tumors without apparent induction of oxidative stress. Interestingly, Dz13-mediated tumor decay was more profound in immunocompetent mice syngeneic to the tumor compared with immunocompromised animals. Immunohistological inspection revealed increased immune and inflammatory cells in Dz13-treated tumors in the immunocompetent mice. In addition, Dz13 mediated tumor regression was prevented by the administration of CD4 or CD8 antibodies, which depleted the mice of the respective T cell subsets. Thus, inhibition of tumor growth by a DNAzyme involves the induction of tumor immunity. These findings suggest that c-Jun inhibition in tumors stimulates apoptosis and adaptive immune mechanisms that attack the tumor. Underpinned by a favorable preclinical safety profile, DNAzymes could provide a new treatment option combining both direct and indirect mechanisms to prevent the growth and spread of non-melanoma skin cancer.
Insights
DNAzymes like Dz13 destabilize c-jun mRNA, promoting tumor cell death. This DNAzyme therapy enhances anti-tumor immunity, offering a novel treatment for skin cancer.
Area of Science:
- Molecular Biology
- Immunology
- Cancer Research
Background:
- DNAzymes are catalytic DNA molecules with therapeutic potential.
- The DNAzyme Dz13 targets and degrades c-jun mRNA, a key regulator in cell proliferation and survival.
Discussion:
- Dz13 treatment led to tumor regression by increasing apoptosis and reducing growth factors.
- Tumor decay was significantly enhanced in immunocompetent hosts, suggesting an immune-mediated component.
- Increased immune and inflammatory cell infiltration was observed in treated tumors from immunocompetent mice.
Key Insights:
- Dz13-induced tumor regression is dependent on adaptive immunity, specifically CD4+ and CD8+ T cells.
- The mechanism involves direct tumor cell apoptosis and the stimulation of anti-tumor immune responses.
- This DNAzyme therapy does not appear to induce significant oxidative stress.
Outlook:
- DNAzymes represent a promising therapeutic strategy for non-melanoma skin cancer.
- Combining direct anti-cancer effects with immune stimulation offers a dual mechanism of action.
- Further preclinical studies support the potential of DNAzymes as a novel cancer treatment option.
Related Concept Videos
Ribozymes
Ribozymes can be...
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Caspases
Restriction Enzymes
The host bacteria protect their own genomic DNA from these enzymes by methylating these sites. Some...
Experimental RNAi

